Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD, FAPM

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia

Education

Overview: Limitations of Current Treatment of Depression Maurizio Fava, MD

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia Dost Ongur, MD, PhD

Assessment and Treatment of Affective Symptoms in Schizophrenia Oliver Freudenreich, MD, FAPM

Optimal Treatment of Psychosis in Bipolar Disorder Sharmin Ghaznavi, MD, PhD